Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations
Keyword(s):
2014 ◽
Vol 25
(2)
◽
pp. 117-146
◽
Keyword(s):
2018 ◽
Vol 264
◽
pp. 367-374
◽
2020 ◽
Vol 1222
◽
pp. 128881
◽
Keyword(s):